| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |